Evidence map›Paper›PMID 29445193›Full record

ArticleCell death & disease2018

Uncoupling FoxO3A mitochondrial and nuclear functions in cancer cells undergoing metabolic stress and chemotherapy.

Valentina Celestini, Tugsan Tezil, Luciana Russo, Candida Fasano, Paola Sanese, Giovanna Forte, Alessia Peserico, Martina Lepore Signorile, Giovanna Longo, Domenico De Rasmo and 10 more

Open access · goldAbstract read
In one paragraph

Article in Cell death & disease, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 53 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. FOXOs: masters of the equilibrium.The FEBS journal · 2022
    Review
  16. Article
  17. Metformin and Cancer, an Ambiguanidous Relationship.Pharmaceuticals (Basel, Switzerland) · 2022
    Review
  18. Identifying novel SMYD3 interactors on the trail of cancer hallmarks.Computational and structural biotechnology journal · 2022
    Article
  19. Mitochondrial sirtuin 3 and various cell death modalities.Frontiers in cell and developmental biology · 2022
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 5 institutions in 2 countries.

Valentina CelestiniDivision of Medical Genetics, Department of Biomedical Sciences and Human Oncology (DIMO), University of Bari Aldo Moro, Bari, 70124, Italy.
Tugsan TezilDivision of Medical Genetics, Department of Biomedical Sciences and Human Oncology (DIMO), University of Bari Aldo Moro, Bari, 70124, Italy.ORCID 0000-0003-0796-3718
Luciana RussoMedical Genetics, National Institute for Gastroenterology, IRCCS 'S. de Bellis', Castellana Grotte (Ba), 70013, Italy.
Candida FasanoMedical Genetics, National Institute for Gastroenterology, IRCCS 'S. de Bellis', Castellana Grotte (Ba), 70013, Italy.
Paola SaneseDivision of Medical Genetics, Department of Biomedical Sciences and Human Oncology (DIMO), University of Bari Aldo Moro, Bari, 70124, Italy.
Giovanna ForteMedical Genetics, National Institute for Gastroenterology, IRCCS 'S. de Bellis', Castellana Grotte (Ba), 70013, Italy.
Alessia PesericoDivision of Medical Genetics, Department of Biomedical Sciences and Human Oncology (DIMO), University of Bari Aldo Moro, Bari, 70124, Italy.
Martina Lepore SignorileDivision of Medical Genetics, Department of Biomedical Sciences and Human Oncology (DIMO), University of Bari Aldo Moro, Bari, 70124, Italy.
Giovanna LongoDivision of Medical Genetics, Department of Biomedical Sciences and Human Oncology (DIMO), University of Bari Aldo Moro, Bari, 70124, Italy.
Domenico De RasmoInstitute of Biomembranes and Bioenergetics, National Research Council (CNR), Bari, 70126, Italy.
Anna SignorileDepartment of Basic Medical Sciences, Neurosciences and Sense Organs, University of Bari Aldo Moro, Bari, 70124, Italy.
Raffaella Maria GadaletaDivision of Digestive Diseases, Department of Surgery and Cancer, Imperial College London, Queen Elizabeth the Queen Mother Wing (QEQM), London, W2 1NY, UK.
Natasha ScialpiMedicina Interna Universitaria Frugoni', Department of Interdisciplinary Medicine, University of Bari Aldo Moro, Bari, 70124, Italy.
Mineko TeraoDepartment of Biochemistry and Molecular Pharmacology/Laboratory of Molecular Biology, IRCCS - Istituto di Ricerche Farmacologiche 'Mario Negri', Milano, 20156, Italy.
Enrico GarattiniDepartment of Biochemistry and Molecular Pharmacology/Laboratory of Molecular Biology, IRCCS - Istituto di Ricerche Farmacologiche 'Mario Negri', Milano, 20156, Italy.
Tiziana CoccoDepartment of Basic Medical Sciences, Neurosciences and Sense Organs, University of Bari Aldo Moro, Bari, 70124, Italy.
Gaetano VillaniDepartment of Basic Medical Sciences, Neurosciences and Sense Organs, University of Bari Aldo Moro, Bari, 70124, Italy.
Antonio MoschettaMedicina Interna Universitaria Frugoni', Department of Interdisciplinary Medicine, University of Bari Aldo Moro, Bari, 70124, Italy.
Valentina GrossiDivision of Medical Genetics, Department of Biomedical Sciences and Human Oncology (DIMO), University of Bari Aldo Moro, Bari, 70124, Italy. grossi.labsimone@gmail.com.
Cristiano SimoneDivision of Medical Genetics, Department of Biomedical Sciences and Human Oncology (DIMO), University of Bari Aldo Moro, Bari, 70124, Italy. cristiano.simone@uniba.it.
University of Bari Aldo Moro · ITGastroenterology Hospital "Saverio de Bellis" · ITMario Negri Institute for Pharmacological Research · ITInstitute of Biomembranes, Bioenergetics and Molecular Biotechnologies · ITQueen Elizabeth the Queen Mother Hospital · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

While aberrant cancer cell growth is frequently associated with altered biochemical metabolism, normal mitochondrial functions are usually preserved and necessary for full malignant transformation. The transcription factor FoxO3A is a key determinant of cancer cell homeostasis, playing a dual role in survival/death response to metabolic stress and cancer therapeutics. We recently described a novel mitochondrial arm of the AMPK-FoxO3A axis in normal cells upon nutrient shortage. Here, we show that in metabolically stressed cancer cells, FoxO3A is recruited to the mitochondria through activation of MEK/ERK and AMPK, which phosphorylate serine 12 and 30, respectively, on FoxO3A N-terminal domain. Subsequently, FoxO3A is imported and cleaved to reach mitochondrial DNA, where it activates expression of the mitochondrial genome to support mitochondrial metabolism. Using FoxO3A

Indexed as

Gene Expression Regulation, NeoplasticAMP-Activated Protein KinasesAnimalsAntineoplastic AgentsApoptosisCell Line, TumorCell NucleusCell SurvivalCisplatinCRISPR-Cas SystemsExtracellular Signal-Regulated MAP KinasesFluorouracilForkhead Box Protein O3Gene EditingGenome, MitochondrialHEK293 CellsAMP-Activated Protein KinasesAntineoplastic AgentsCisplatinExtracellular Signal-Regulated MAP KinasesFluorouracilForkhead Box Protein O3FOXO3 protein, humanIrinotecanMAP Kinase Kinase KinasesMetformin

Identifiers

PMID29445193
PMCPMC5833443
OpenAlexW2787996399

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.